中文| English
Home
About
Company Introduction
Vision and Mission
Subsidiary enterprises
Contact Us
Ability
Core business
Brand Story
Core Advantages
Blog
Company News
Investor Relations
Sustainable
Our Commitment
Our goal
Our actions
Social honor
Social Responsibility Report
Cultural Heritage
Tibetan medical knowledge
File Download
Technological innovation
Evidence-based medicine
Care for Health
Consumer Q&A
Tibetan medical consultation
Human development
Why choose us?
Industry Standards
Training and Development
Employee Highlights
Qizheng Tibetan Medicine has been awarded the honorary title of “National Civilized Unit.”
2025-05-30
Qizheng Tibetan Medicine: Awarded the Title of “National Advanced Collective in the Industrial and Information Technology System”
2025-04-30
Qizheng Tibetan Medicine Achieves Record-Breaking Performance in 2024; Consistent and Stable Dividends Highlight Strong Growth Momentum.
2025-04-26
Qizheng Tibetan Medicine Releases 2024 ESG Report: A Green and Sustainable Supply Chain Safeguards the Future of the Industry
Qizheng Tibetan Medicine’s 2024 financial report shines: Both revenue and net profit excluding non-recurring items grew at double-digit rates, and its multi-product, omni-channel marketing strategy has yielded remarkable results.
Qizheng Tibetan Medicine: In 2024, its operating revenue reached 2.338 billion yuan, a year-on-year increase of 14.32%.
Operating revenue has grown for eight consecutive years! In 2024, Qizheng Tibetan Medicine’s operating revenue increased by 14.32%, and the company plans to distribute a cash dividend of 3.8 yuan for every 10 shares held.
Announcement of the New Version of the Package Insert for Liu Wei Neng Xiao Tablets
2025-04-03
Announcement of the New Version of the Instruction Manual for Shiwuwei Rupeng Pills
2025-03-29
Promoting the Development of Traditional Chinese Medicine: Qizheng Tibetan Medicine Leads the New Journey of the Tibetan Medicine Industry with High Quality.
2025-03-25
Public Welfare Project to Provide Tibetan Medical Treatment for Rural Patients with Ankylosing Spondylitis Launched
2025-01-08
Qizheng Tibetan Medicine Receives Prestigious Award for Promoting the Inheritance of Tibetan Medical Culture
2024-12-26
The kickoff meeting for the top-level design of the Phase III clinical trial protocol for Bai Mai Ointment in the treatment of diabetic peripheral neuropathy will be held.
2024-12-12
Qizheng Tibetan Medicine has been invited to participate in the 29th Macao International Trade and Investment Fair, focusing on the registration of Chinese medicine in Macao and its international expansion strategy.
2024-10-27
The Community for the Development of Traditional Chinese Medicine Respiratory Health Established; Qizheng Tibetan Medicine Becomes One of the First Members